WORXE Worlds Online Inc

MariMed Wins High Times Cultivation Cup Award for Its Nature’s Heritage Brand and MetroSouth Award for Best Dispensary

MariMed Wins High Times Cultivation Cup Award for Its Nature’s Heritage Brand and MetroSouth Award for Best Dispensary

NORWOOD, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) ("MariMed" or the "Company"), a leading multi-state cannabis operator focused on improving lives every day, continued its winning streak of earning industry recognition for its high-quality products and dispensaries. In a competition this week of the best flower produced in the state, the Company’s top-selling Nature’s Heritage premium flower brand took home a Bronze Medal for its Crescendo hybrid strain at the High Times Cannabis Cup Massachusetts 2021. The honor comes on the heels of MariMed’s Panacea Wellness dispensary being recognized as the Best Cannabis Dispensary in the Best of the Best MetroSouth (MA) Competition.

The two awards are just the latest in a year of accolades for MariMed’s brands and illustrate that the Company’s commitment to craft cultivation at scale, including its heavy emphasis on individualized, hands-on care for each and every plant, translates to exceptional products. Earlier this year, Nature’s Heritage came in second place in the Massachusetts Cultivator’s Cup, and the Company’s Betty’s Eddies fruit chews, which are handcrafted with full-spectrum cannabis oil, organic fruits, and vegetables, was named Best Edible in the Reddit Sparkie Awards.

Both Nature’s Heritage and Betty’s Eddies brands are among the top sellers in states in which they’re available.

“Cannabis consumers tell us every day with their wallets that they love our brands and our dispensaries, but earning the recognition that comes with an award is of course gratifying as well. We’re thankful to High Times, MetroSouth, and all the groups that have honored us over the years,” said MariMed CEO Bob Fireman. “We’re also thankful to the employees in our cultivation, processing and dispensary facilities who share our vision for creating great products that improve people’s lives and making it a reality.”

About MariMed, Inc.

MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies®, Nature’s Heritage™, Bourne Baking Co., and K-Fusion®. For additional information, visit marimedinc.com.

Company Contact:

Howard Schacter

Chief Communications Officer

Email:

Investor Relations Contact:

Steve West

Vice President, Investor Relations

Email:

Media Contact:

Trailblaze PR

Email:



EN
04/11/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Worlds Online Inc

 PRESS RELEASE

MariMed Extends Series B Preferred Stock Obligation Through 2031, Stre...

MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure NORWOOD, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today that it has entered into a Restructuring and Exchange Agreement (the “Agreement”) with the holders (the “Holders”) of its $14.725 million Series B Convertible Preferred Stock (the “Series B Obligation”). The restructuring extends the maturity of the Company’s obligations on favorable market term...

 PRESS RELEASE

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date NORWOOD, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- . (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its fourth quarter and full year 2025 financial results on March 11, 2026 after the markets close. Management will host a conference call on March 12, 2026 at 8:00 a.m. EDT to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations website at . A playback of the call will...

 PRESS RELEASE

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Valentine’s S...

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Valentine’s Seasonal, Berry In Love Betty The Brand’s First-Ever Swirled Chew Combines Strawberry and Chocolate Flavors Plus CBG and Horny Goat Weed for Libido-enhancing Fun NORWOOD, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- ™, the all-natural cannabis fruit chews handcrafted for specific health and wellness effects, is expanding its lineup with a new limited-edition batch of strawberry chocolate chews in time for Valentine’s Day: Berry In Love Betty. Betty’s Eddies is one of the top-selling and award-winning brands developed and d...

 PRESS RELEASE

MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand ...

MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand in Rhode Island NORWOOD, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced the launch of a hemp-derived THC version of its hydrating drink mix brand in Rhode Island. The launch represents a capital-efficient opportunity for the Company to expand Vibations into the rapidly growing hemp THC beverage category through an established retail channel, without incremental cultivation or retail infrast...

 PRESS RELEASE

MariMed Statement on Historic Rescheduling of Cannabis

MariMed Statement on Historic Rescheduling of Cannabis NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the following statement from CEO Jon Levine today. “We commend President Trump and the Trump Administration for reclassifying cannabis as a Schedule III drug. This is the single greatest cannabis reform in US history and will have far-reaching benefits for years to come. Most important, the reclassification means the Federal government officially a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch